stocks logo

TSBX

Turnstone Biologics Corp
$
0.360
+0.005(1.408%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.3601
Open
0.3601
VWAP
--
Vol
--
Mkt Cap
69.15M
Low
0.3601
Amount
--
EV/EBITDA(TTM)
--
Total Shares
23.13M
EV
-8.47M
EV/OCF(TTM)
--
P/S(TTM)
--
Turnstone Biologics Corp. is a biotechnology company. The Company has been focused on the development of a differentiated approach to treating and curing patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy. It has discontinued all sponsored clinical studies evaluating TIDAL-01 for all indications, and pursuit of strategic alternatives to enhance and preserve stockholder value, which may include exploration and evaluation of strategic options like a merger, reverse merger, other business combinations, sale of assets, licensing, or other strategic transactions.
Show More

Valuation Metrics

The current forward P/E ratio for Turnstone Biologics Corp (TSBX.O) is -0.63, compared to its 5-year average forward P/E of -0.83. For a more detailed relative valuation and DCF analysis to assess Turnstone Biologics Corp 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-0.83
Current PE
-0.63
Overvalued PE
0.05
Undervalued PE
-1.71

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.16
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.88
Undervalued EV/EBITDA
-0.57

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

Annual
Quarterly
FY2025Q2
0.00
Total Revenue
FY2025Q2
YoY :
-83.41%
-3.66M
Operating Profit
FY2025Q2
YoY :
-74.23%
-5.49M
Net Income after Tax
FY2025Q2
YoY :
-73.91%
-0.24
EPS - Diluted
FY2025Q2
YoY :
-73.15%
-4.30M
Free Cash Flow
FY2025Q2
N/A
Gross Profit Margin - %
FY2025Q2
N/A
FCF Margin - %
FY2025Q2
N/A
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

TSBX News & Events

Events Timeline

2025-08-11 (ET)
2025-08-11
09:09:02
Xoma closes tender offer for Turnstone Biologics
select
2025-06-27 (ET)
2025-06-27
07:36:08
Xoma to acquire Turnstone Biologics for $0.34 in cash per share
select
2025-03-30 (ET)
2025-03-30
17:40:46
Turnstone Biologics reports Q4 EPS (56c) vs (73c) last year
select
Sign Up For More Events

News

7.0
07-05Globenewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMS, TSBX, BGFV on Behalf of Shareholders
7.0
06-30Globenewswire
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Turnstone Biologics Corp. (NASDAQ: TSBX)
8.5
06-27NASDAQ.COM
XOMA To Acquire Turnstone Biologics For $0.34/Shr Plus Contingent Value Right
Sign Up For More News

FAQ

arrow icon

What is Turnstone Biologics Corp (TSBX) stock price today?

The current price of TSBX is 0.3601 USD — it has increased 1.41 % in the last trading day.

arrow icon

What is Turnstone Biologics Corp (TSBX)'s business?

arrow icon

What is the price predicton of TSBX Stock?

arrow icon

What is Turnstone Biologics Corp (TSBX)'s revenue for the last quarter?

arrow icon

What is Turnstone Biologics Corp (TSBX)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Turnstone Biologics Corp (TSBX)'s fundamentals?

arrow icon

How many employees does Turnstone Biologics Corp (TSBX). have?

arrow icon

What is Turnstone Biologics Corp (TSBX) market cap?